Compound ID | 1259

Update compound information

MBN-101

Spectrum of activity: Gram-positive  &  Gram-negative
Details of activity: Antibacterial agent against a broad range of gram-positive and gram-negative pathogens
Institute where first reported: Microbion Corporation
Year first mentioned: 2015
Highest developmental phase: Phase 2
Development status: Active
Chemical structure(s):
Click here for structure editor
Molecular weight: 694.52
Iso. SMILES: C1CS[Bi](S1)SCCS[Bi]2SCCS2
InChI Key: GUTNLKRPYCTIHX-UHFFFAOYSA-H
Can. SMILES: C1CS[Bi](S1)SCCS[Bi]2SCCS2
InChI: InChI=1S/3C2H6S2.2Bi/c3*3-1-2-4;;/h3*3-4H,1-2H2;;/q;;;2*+3/p-6
External links:
PubChem link: https://pubchem.ncbi.nlm.nih.gov/compound/10327332
Guide to Pharmacology: pravibismane
Citations:
  • https://www.escmid.org/escmid_publications/escmid_elibrary/?q=MBN-101&id=2173&L=0&x=0&y=0&tx_solr%5Bfilter%5D%5B0%5D=main_filter_eccmid%253Atrue
  • https://microbioncorp.com/pipeline/

    • AntibioticDB is supported by GARDP.

    If you have feedback, experience problems, or are interested in a collaboration, please contact us. | Terms and conditions

    The content of this site is intended for educational and scientific research purposes only and not as a source of medical advice or consultation.